Table 2.
Information of prognostic immune genes.
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| Immune gene | HR | 95% CI | P | Coefficient | HR | 95% CI | P |
| ADAMTS8 (high/low) | 0.601 | 0.453 | 0.796 | −0.499 | 0.607 | 0.444–0.832 | 0.002 |
| IFNG (high/low) | 0.627 | 0.472 | 0.833 | −0.698 | 0.497 | 0.335–0.739 | <0.001 |
| XG (high/low) | 1.373 | 1.036 | 1.819 | 0.790 | 2.203 | 1.520–3.193 | <0.001 |
| APOA5 (high/low) | 1.465 | 1.084 | 1.979 | 0.645 | 1.906 | 1.331–2.730 | <0.001 |
| SIAH2 (high/low) | 0.686 | 0.519 | 0.908 | −0.901 | 0.406 | 0.264–0.624 | <0.001 |
| C2CD2 (high/low) | 1.327 | 1.004 | 1.753 | 1.117 | 3.056 | 1.742–5.361 | <0.001 |
| STAR (high/low) | 0.631 | 0.477 | 0.835 | −0.507 | 0.602 | 0.432–0.839 | 0.003 |
| CAMP (high/low) | 0.740 | 0.559 | 0.979 | −0.321 | 0.725 | 0.580–0.907 | 0.005 |
| CDH19 (high/low) | 0.676 | 0.510 | 0.895 | −0.261 | 0.771 | 0.648–0.916 | 0.003 |
| NTSR1 (high/low) | 1.410 | 1.068 | 1.860 | 0.382 | 1.465 | 1.162–1.847 | <0.001 |
| PCDHA1 (high/low) | 1.475 | 1.116 | 1.950 | 0.331 | 1.392 | 1.125–1.723 | 0.002 |
| AMELX (high/low) | 1.488 | 1.019 | 2.172 | 0.706 | 2.026 | 1.236–3.322 | 0.005 |
| FREM1 (high/low) | 0.678 | 0.512 | 0.898 | −0.655 | 0.520 | 0.362–0.747 | <0.001 |
| CLEC10A (high/low) | 0.699 | 0.528 | 0.925 | 1.082 | 2.950 | 1.756–4.957 | <0.001 |
| CD1B (high/low) | 0.729 | 0.550 | 0.966 | −0.497 | 0.608 | 0.407–0.909 | 0.015 |
| CD6 (high/low) | 0.619 | 0.467 | 0.821 | −0.909 | 0.403 | 0.215–0.755 | 0.005 |
| LTA (high/low) | 0.730 | 0.551 | 0.967 | 0.620 | 1.860 | 1.048–3.300 | 0.034 |
The medians of gene expression values were used as cutoff values to stratify gene expression values into high expression group (as value 1) and low expression group (as value 0). HR, hazard ratio; CI, confidence interval.